Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $346.5600 (-2.83%) ($344.6264 - $357.9200) on Mon. Nov. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 32 | Latest Price | $346.5600(-2.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(60%) XLV(49%) IVW(43%) IWF(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -1.025% in a week (0% probabilities). VXX(-11%) UUP(-11%) TLT(-7%) DIA(-5%) VIXM(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
Resistance Level | $361.25 | 5 Day Moving Average | $357.68(-3.11%) | 10 Day Moving Average | $353.29(-1.9%) | 20 Day Moving Average | $361.25(-4.07%) | To recent high | -15.2% | To recent low | 3.2% | Market Cap | $36.745b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |